Feng Gu
Peking Union Medical College
5 Papers
Feng Gu is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Internal medicine & Clinical endpoint. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
The effectiveness and safety of Chinese Patent Medicines based on syndrome differentiation in patients following percutaneous coronary intervention due to acute coronary syndrome (CPM trial): A nationwide Cohort Study.
Rui-Na Bai,Qiaoning Yang,Ruixi Xi,Qianzi Che,Yang Zhao,Ming Guo,G Dong,Zhuye Gao,Changgeng Fu,Pei-Li Wang,Feng Gu,Jianpeng Du,Da-wu Zhang,Wen-hui Duan,Lizhi Li,Dazhuo Shi +15 more
TL;DR: Wang et al. as discussed by the authors evaluated the effectiveness and safety of CPM based on syndrome differentiation in patients following percutaneous coronary intervention (PCI) due to acute coronary syndrome (ACS).
9
Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention: A multicenter randomized controlled trial
Pei-Li Wang,Lei Zhang,Shao-Li Wang,Qiaoning Yang,Zhuye Gao,Jianpeng Du,Da-wu Zhang,Changgeng Fu,Feng Gu,Hao Xu,Li-zhi Li,Cheng-Long Wang,Dazhuo Shi +12 more
TL;DR: CHMs for benefiting qi and activating blood circulation adjunctive to conventional treatment improved clinical outcomes for patients with ACS after PCI in long-term follow-up.
4
1-Year Outcomes of a Multicenter Randomized Controlled Trial of the Ankura II Thoracic Endoprosthesis for the Endovascular Treatment of Stanford Type B Aortic Dissections
Chang Shu,Hao He,Weiguo Fu,Wei Guo,Ming Li,Erping Xi,Shuguang Guo,Xueming Chen,Zhanxiang Xiao,Zhiqiang Yu,Jianhua Huang,Xiangchen Dai,Zhiwei Wang,Wei Li,Qi Zheng,Quanming Li,Lunchang Wang,Xin Li,Junwei Wang,Feng Gu +19 more
TL;DR: The one-year outcomes from this prospective, randomized, multicenter study demonstrate that Ankura II stent graft shows comparable results to Ankura for treating TBADs, resulting in low mortality rates, MAEs and reintervention rates.
Clinical efficacy of traditional chinese medicine on acute myocardial infarction: a prospective cohort study.
Wen-hui Duan,Fang Lu,Li-zhi Li,Cheng-long Wang,Jiangang Liu,Qiaoning Yang,Feng Gu,Lei Zhang,Dazhuo Shi +8 more
TL;DR: CM therapy could decrease CM syndrome scores and blood-stasis syndrome score, reduce the rehospitalization rate during 6-month follow-up due to angina and heart dysfunction and diabetes mellitus were hazard factors to end-point, whereas CM, PCI and ACE inhibitors were protective factors.